SEC 13F Intelligence

Managers / Q4 2020 · view latest →

BRIDGER MANAGEMENT, LLC

CIK 0001166309 · 90 PARK AVENUE, 40TH FLOOR, NEW YORK, NY, 10016 · 212-918-0820

Reported Value
$1.3B
Q4 2020
Positions
39
Filings on Record
37
2019–present window
Filed
Feb 16, 2021
original filing

Summary

Bridger Management, LLC reported $1.3B in U.S.-listed holdings across 39 positions for Q4 2020.

Its largest position, American Well, represents 9.0% of the portfolio.

Compared with Q3 2020, the fund opened 8 new positions and exited 5.

Portfolio Metrics

Turnover
+16.0%
vs prior filed quarter
Top-10 Concentration
+52.3%
share of reported value
Largest Position
+9.0%
American Well
New / Exited
8 / 5
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $1.2BQ4 ’18Q1 ’19: $1.3BQ2 ’19: $1.3BQ3 ’19: $1.2BQ4 ’19: $1.4BQ4 ’19Q1 ’20: $864MQ2 ’20: $1.1BQ3 ’20: $1.3BQ4 ’20: $1.3BQ4 ’20Q1 ’21: $1.1BQ2 ’21: $1.1BQ3 ’21: $855MQ4 ’21: $773MQ4 ’21Q1 ’22: $610MQ2 ’22: $444MQ3 ’22: $330MQ4 ’22: $247MQ4 ’22Q1 ’23: $268MQ2 ’23: $300MQ3 ’23: $272MQ4 ’23: $260MQ4 ’23Q1 ’24: $222MQ2 ’24: $194MQ3 ’24: $200MQ4 ’24: $186MQ4 ’24Q1 ’25: $201MQ2 ’25: $170MQ3 ’25: $186MQ4 ’25: $156MQ4 ’25Q1 ’26: $128Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 78.8%Other: 16.8%ADR: 4.4%
  • Common Stock · 78.8% · $1.0B
  • Other · 16.8% · $220M
  • ADR · 4.4% · $58M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
SQZBSQZ BIOTECHNOLOGIES CONEW+807.8K807.8K+$23M$23M
LIVANOVA PLCNEW+216.5K216.5K+$14M$14M
ZBHZIMMER BIOMET HOLDINGS INCNEW+89.1K89.1K+$14M$14M
FCNCAFIRST CTZNS BANCSHARES INC NNEW+20.0K20.0K+$11M$11M
AVANTI ACQUISITION CORPNEW+1.00M1.00M+$11M$11M
ACIES ACQUISITION CORPNEW+900.0K900.0K+$10M$10M
CONSONANCE HFW ACQUISITION CNEW+700.0K700.0K+$7M$7M
DMTKQDERMTECH INCNEW+180.3K180.3K+$6M$6M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2020

39 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1AMERICAN WELL CORPCL A8.95%$117M4.63M
2CZRCAESARS ENTERTAINMENT INC NEhistory →COM6.29%$82M1.11M
3GDDYGODADDY INChistory →CL A6.01%$79M950.2K
4NTRANATERA INChistory →COM5.34%$70M704.0K
5ALXNALEXION PHARMACEUTICALS INChistory →COM5.03%$66M422.3K
6POSTPOST HLDGS INChistory →COM4.22%$55M547.2K
7ROSTROSS STORES INChistory →COM4.21%$55M449.8K
8CHTRCHARTER COMMUNICATIONS INC Nhistory →CL A4.15%$54M82.3K
9ALCON AGORD SHS4.14%$54M822.5K
10UBERUBER TECHNOLOGIES INChistory →COM3.96%$52M1.02M
11MRKMERCK & CO. INChistory →COM3.68%$48M589.5K
12DWDMORGAN STANLEYhistory →COM NEW3.42%$45M653.5K
13GDSGDS HLDGS LTDhistory →SPONSORED ADS3.28%$43M459.9K
14ALNYALNYLAM PHARMACEUTICALS INChistory →COM3.11%$41M313.6K
15LKQ1LKQ CORPhistory →COM3.02%$40M1.13M
16VRSNVERISIGN INChistory →COM2.85%$37M172.6K
17HCAHCA HEALTHCARE INChistory →COM2.74%$36M218.5K
18INCYINCYTE CORPhistory →COM2.68%$35M404.6K
19ETSYETSY INChistory →COM2.52%$33M185.7K
20ATRAGBXATARA BIOTHERAPEUTICS INChistory →COM2.28%$30M1.52M
21IRWDIRONWOOD PHARMACEUTICALS INChistory →COM CL A2.14%$28M2.47M
22FTDRFRONTDOOR INChistory →COM1.82%$24M475.0K
23SQZBSQZ BIOTECHNOLOGIES COhistory →COM1.79%$23M807.8K
24PVG1EURPRETIUM RES INChistory →COM1.23%$16M1.41M
25TEVATEVA PHARMACEUTICAL INDS LTDhistory →SPONSORED ADS1.10%$14M1.50M
26LIVANOVA PLCSHS1.09%$14M216.5K
27LBRDALIBERTY BROADBAND CORPhistory →COM SER A1.06%$14M87.8K
28ZBHZIMMER BIOMET HOLDINGS INChistory →COM1.05%$14M89.1K
29TGTXTG THERAPEUTICS INChistory →COM1.02%$13M256.9K
30FCNCAFIRST CTZNS BANCSHARES INC Nhistory →CL A0.88%$11M20.0K
31AVANTI ACQUISITION CORPUNIT 99/99/99990.83%$11M1.00M
32DC4DEXCOM INCCOM0.74%$10M26.1K
33ACIES ACQUISITION CORPUNIT 11/30/20270.74%$10M900.0K
34CONSONANCE HFW ACQUISITION CUNIT 99/99/99990.56%$7M700.0K
35QTRXQUANTERIX CORPCOM0.48%$6M135.7K
36LABORATORY CORP AMER HLDGSCOM NEW0.48%$6M30.6K
37DMTKQDERMTECH INCCOM0.45%$6M180.3K
38ARNAEURARENA PHARMACEUTICALS INCCOM NEW0.40%$5M68.8K
39ALECALECTOR INCCOM0.26%$3M229.1K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$128M24May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$156M24Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$186M28Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$170M25Aug 11, 202513F-HRchanges · EDGAR ↗
Q1 2025$201M29May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$186M28Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$200M29Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$194M28Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$222M31May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$260M28Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$272M31Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$300M29Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$268M28May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$247M23Feb 15, 202313F-HRchanges · EDGAR ↗
Q3 2022$330M44Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$444M43Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$610M52May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$773M44Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$855M46Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.1B44Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.1B42May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.3B39Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.3B36Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.1B35Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$864M36May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.4B35Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$1.2B30Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.3B31Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.3B33May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$1.2B34Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.